Product
digoxin
4 clinical trials
6 indications
Indication
HealthyIndication
Solid TumorIndication
AdultIndication
Overweight SubjectsIndication
Obese SubjectsIndication
CancerClinical trial
A Phase I Study to Assess Safety, Tolerability, Pharmacokinetics and Effect of Food on Multiple Rising Oral Doses of BI 1839100 (Single-blind, Randomised, Placebo-controlled, Parallel Group Design) and the Effect of Multiple Doses of BI 1839100 on the Single Dose Pharmacokinetics of Cytochrome P450 Substrate (Midazolam), a P Glycoprotein Substrate (Digoxin) and OATP Substrate (Rosuvastatin) Administered Orally (Open-label, Fixed-sequence) in Healthy Male SubjectsStatus: Recruiting, Estimated PCD: 2024-06-07
Clinical trial
a Single-center, Non-randomized, Open-label, Self-controlled Phase 1 Clinical Study to Evaluate Drug-drug Interactions of JMKX001899 Tablets in Healthy SubjectsStatus: Not yet recruiting, Estimated PCD: 2024-05-31
Clinical trial
A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese SubjectsStatus: Completed, Estimated PCD: 2023-08-18
Clinical trial
A Phase 1, Open-label, Multiple-probe Drug-drug Interaction Study to Determine the Effect of Rucaparib on Pharmacokinetics of Caffeine, S-Warfarin, Omeprazole, Midazolam, and Digoxin in Patients With Advanced Solid TumorsStatus: Completed, Estimated PCD: 2017-03-01